Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and d-arg-dmt-lys-phe-nh2

tolvaptan has been researched along with d-arg-dmt-lys-phe-nh2 in 1 studies

Compound Research Comparison

Studies
(tolvaptan)		Trials
(tolvaptan)		Recent Studies (post-2010)
(tolvaptan)		Studies
(d-arg-dmt-lys-phe-nh2)		Trials
(d-arg-dmt-lys-phe-nh2)		Recent Studies (post-2010) (d-arg-dmt-lys-phe-nh2)
96717278616313158

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bhardwaj, G; Dai, DF; Daneshgar, N; Horstmann, MM; Lan, RS; Liang, PI; O'Neill, BT; Pack, L; Penniman, CM1

Other Studies

1 other study(ies) available for tolvaptan and d-arg-dmt-lys-phe-nh2

ArticleYear
Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations.
    Kidney international, 2022, Volume: 101, Issue:5

    Topics: Animals; Animals, Newborn; Female; Humans; Male; Mice; Mutation; Oligopeptides; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Pregnancy; Tolvaptan

2022